TIMP3 may have a therapeutic potential to prevent adverse remodeling after myocardial infarction as demonstrated by the beneficial effects of direct TIMP3 injection into the infarcted myocardium in a pig MI model.31 This approach could be beneficial for the patients who may undergo the coronary artery bypass graft (CABG) surgery. The gene discussed is TIMP3; the disease is myocardial infarction.